Evidence map›Paper›PMID 32835225›Full record

ArticleImplementation science communications2020

Multi-factorial barriers and facilitators to high adherence to lung-protective ventilation using a computerized protocol: a mixed methods study.

Andrew J Knighton, Jacob Kean, Doug Wolfe, Lauren Allen, Jason Jacobs, Lori Carpenter, Carrie Winberg, Jay G Berry, Ithan D Peltan, Colin K Grissom and 1 more

Open access · goldAbstract read
In one paragraph

Article in Implementation science communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.4field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 23 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. ARDS, guidelines and ANZ practice: The persistent disconnect.Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine · 2024
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Andrew J KnightonImplementation Science Research, Healthcare Delivery Institute, Intermountain Healthcare, 5026 South State Street, 3rd Floor, Murray, UT 84107 USA.
Jacob KeanPopulation Health Sciences, University of Utah School of Medicine, 295 Chipeta Way, Salt Lake City, UT 84108 USA.
Doug WolfeBest Practice Implementation, Healthcare Delivery Institute, Intermountain Healthcare, 5026 South State Street, 3rd Floor, Murray, UT 84107 USA.
Lauren AllenBest Practice Implementation, Healthcare Delivery Institute, Intermountain Healthcare, 5026 South State Street, 3rd Floor, Murray, UT 84107 USA.
Jason JacobsPulmonary and Critical Care Research, Intermountain Healthcare, 5121 S Cottonwood St, Murray, UT 84107 USA.
Lori CarpenterPulmonary and Critical Care Research, Intermountain Healthcare, 5121 S Cottonwood St, Murray, UT 84107 USA.
Carrie WinbergPulmonary and Critical Care Research, Intermountain Healthcare, 5121 S Cottonwood St, Murray, UT 84107 USA.
Jay G BerryComplex Care, Division of General Pediatrics, Boston Children's Hospital, Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115 USA.
Ithan D PeltanDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, USA.
Colin K GrissomIntermountain Healthcare, 5121 S Cottonwood St, Murray, UT 84107 USA.
Raj SrivastavaHealthcare Delivery Institute, Intermountain Healthcare, 5026 South State Street 3rd Floor, Murray, UT 84107 USA.
Intermountain Healthcare · USState Street (United States) · USCotton (United States) · USUniversity of Utah · USHarvard University · US

Funding

Utah Center for Clinical and Translational ScienceUL1TR002538 · NCATS · UNIVERSITY OF UTAH · PI HESS, RACHEL, MAJERSIK, JENNIFER JUHL · 2018 to 2022
$26.0M
Vascular Health and Risk Factors in Children with Down SyndromeKL2TR002539 · NCATS · UNIVERSITY OF UTAH · PI MURTAUGH, MAUREEN A, NYGAARD, INGRID E · 2018 to 2022
$4.3M
Implementation of Computerized Clinical Support for Mechanical Ventilation of Patients with Acute Respiratory Distress SyndromeU01HL143505 · NHLBI · IHC HEALTH SERVICES, INC. · PI GRISSOM, COLIN KERST, SRIVASTAVA, RAJENDU · 2018 to 2019
$1.1M
Prehospital Activation of ED Teams to Improve Sepsis CareK23GM129661 · NIGMS · IHC HEALTH SERVICES, INC. · PI PELTAN, ITHAN DANIEL · 2019 to 2023
$786k
NCATS NIH HHS KL2 TR002539NCATS NIH HHS UL1 TR002538NHLBI NIH HHS U01 HL143505NIGMS NIH HHS K23 GM129661
6 · The paper itself

Abstract

backgroundLung-protective ventilation (LPV) improves outcomes for patients with acute respiratory distress syndrome (ARDS) through the administration of low tidal volumes (≤ 6.5 ml/kg predicted body weight [PBW]) with co-titration of positive end-expiratory pressure and fraction of inspired oxygen. Many patients with ARDS, however, are not managed with LPV. The purpose of this study was to understand the implementation barriers and facilitators to the use of LPV and a computerized LPV clinical decision support (CDS) tool in intensive care units (ICUs) in preparation for a pilot hybrid implementation-effectiveness clinical trial.

methodsWe performed an explanatory sequential mixed methods study from June 2018 to March 2019 to evaluate the variation in LPV adherence across 17 ICUs in an integrated healthcare system with > 4000 mechanically ventilated patients annually. We analyzed 47 key informant interviews of ICU physicians, respiratory therapists (RTs), and nurses in 3 of the ICUs using a qualitative content analysis paradigm to investigate site variation as defined by adherence level (low, medium, high) and to identify barriers and facilitators to LPV and LPV CDS tool use.

resultsForty-two percent of patients had an initial set tidal volume of ≤ 6.5 ml/kg PBW during the measurement period (site range 21-80%). LPV CDS tool use was 28% (site range 6-91%). This study's main findings revealed multi-factorial facilitators and barriers to use that varied by ICU site adherence level. The primary facilitator was that LPV and the LPV CDS tool could be used on all mechanically ventilated patients. Barriers included a persistent gap between clinician attitudes regarding the use of LPV and actual use, the perceived loss of autonomy associated with using a computerized protocol, the nature of physician-RT interaction in ventilation management, and the lack of clear organization measures of success.

conclusionsVariation in adherence to LPV persists in ICUs within a healthcare delivery system that was an early adopter of LPV. Potentially promising strategies to increase adherence to LPV and the LPV CDS tool for ARDS patients include initiating low tidal ventilation on all mechanically ventilated patients, establishing and measuring adherence measures, and focused education addressing the physician-RT interaction. These strategies represent a blueprint for a future hybrid implementation-effectiveness trial.

Indexed as

Acute respiratory distress syndrome (ARDS)Barriers and facilitatorsClinical decision supportComputerized protocolImplementationMechanical ventilationMixed methods

Identifiers

PMID32835225
PMCPMC7385713
OpenAlexW3045747519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.